Home |eStore | Topic Map | Site Map | Log In
Membership  |  Publications  |  Meetings  |  Education  |  Awards & Grants  |  Policy  |  International  |  Academy  |  Media Info



Public Policy Page Contents



Issues

PSAB Documents (Statements, Reports and Testimony)

FY 2010 R&D Funding

Contact Congress (Legislative Communications Site)

Clinical Microbiology Resources

Public and Scientific Affairs Board Information

Federal and State Government Links

Congressional Science Fellowship



Check Here for Critical Public Policy Information



Clinical Microbiology Issues Update for June 2009

Federal Funding for FY 2010: Biomedical and Life Sciences Research

Select Agent Regulation Updates

Sentinel Laboratory Guidelines

Visa Information

Committee on the Status of Women in Microbiology

Committee on Microbiological Issues Impacting Minorities
Return to Home

What's New in Public and Scientific Policy

The Committees on Laboratory Practices and Professional Affairs of ASM’s Public and Scientific Affairs Board submitted comments to the Centers for Disease Control and Prevention on its draft Guideline, Prevention of Catheter-Associated Urinary Tract Infections 2008.
 
CDC Guideline on the Prevention of Catheter-Associated Urinary Tract Infections 2008
June 23, 2009
The Committees on Laboratory Practices and Professional Affairs of ASM’s Public and Scientific Affairs Board submitted comments to the Centers for Disease Control and Prevention on its draft Guideline, Prevention of Catheter-Associated Urinary Tract Infections 2008.
 
Education and Scientific Societies Recommendations to Improve Visa Problems
June 10, 2009
The ASM joined about 30 academic and scientific groups in a letter to the Departments of State and Homeland Security and to the Office of Science and Technology Policy addressing steps to resolve visa problems that impede travel by foreign scientists and scholars to the US.
 
Federal Funding for FY 2010 - Biomedical and Life Sciences Research
May 26, 2009
A compilation of the ASM recommendations to Congress for FY 2010 funding for the National Institutes of Health, the Centers for Disease Control and Prevention, the Food and Drug Administration, the National Science Foundation, the Department of Agriculture, the Environmental Protection Agency and the Department of Energy.
 
The NIH Office of Biotechnology Activities Holds IBC Workshop
May 14, 2009
The NIH OBA will hold a workshop, "Institutional Biosafety Committees: Promoting Optimal Practice Now and in the Future" on June 24-26 at the Hyatt Regency Crystal City, Arlington, VA.  The ASM is participating in the workshop.
 
May 12, 2009
On May 7, President Obama released the Administration’s Fiscal Year 2010 Budget. The ASM Office of Public Affairs has developed a chart highlighting the funding levels for science and public health programs of interest to microbiology.
 
ASM Signs onto Clinical Laboratory Coalition Health Care Reform Principles
May 5, 2009
The ASM is a member of the Clinical Laboratory Coalition, which recently released a new document entitled, "Health Care Reform Principles."
 
April 28, 2009 - ASM Supports USDA Agricultural Research Funding
April 28, 2009
The ASM has partnered with a coalition of scientific organizations to develop a letter of support for the Agriculture and Food Research Initiative (AFRI), a USDA competitive grants program created in the Food, Conservation, and Energy Act of 2008. AFRI is the successor to the National Research Initiative (NRI) and the Initiative for Future Agriculture and Food Systems (IFAFS) and is housed within the National Institute of Food and Agriculture (NIFA) which will soon replace the Cooperative State Research, Education, and Extension Service (CSREES).
 
ASM Comments on Revisions to the NIH Guidelines for Research Involving Recombinant DNA Molecules
April 9, 2009
The American Society for Microbiology submitted comments on the proposed revisions to the NIH Guidelines for Research Involving Recombinant DNA Molecules, published in the March 4, 2009 Federal Register.
 
March 19, 2009
As a result of the American Recovery and Reinvestment Act (ARRA) of 2009, the National Institute of Allergy and Infectious Diseases (NIAID) has an additional $1.12 billion to fund projects and resources. NIAID will spend approximately 75 percent of its ARRA funds on unsolicited grants.
 
ASM Presentation to the Executive Order Working Group on Strengthening Biosecurity
March 18, 2009
ASM made recommendations to assure laboratory biosecurity and biosafety before the Working Group on Strengthening Biosecurity.
 
On February 25, the House Committee passed the Omnibus Appropriations Act of 2009. The ASM office of Public Affairs has developed a chart with preliminary information describing the funding levels for public health and science programs of interest to microbiology. Additional details will be posted as they become available.
 
ASM Comments on FDA Federal Register Notice, Participation of Certain Population Subsets in Clinical Drug Trials
February 28, 2009
The ASM submitted comments on FDA Federal Register Notice, Participation of Certain Population Subsets in Clinical Drug Trials.  The ASM’s Committee on Microbiological Issues Impacting Minorities (CMIIM) reviewed the notice and drafted the comments.
 
American Recovery and Reinvestment Act of 2009
February 17, 2009
A House and Senate conference report was agreed to on the American Recovery and Reinvestment Act of 2009 and was signed by President Obama on February 17. The ASM office of Public Affairs has developed a chart with preliminary information describing the funding levels for public health and science programs of interest to microbiology. Additional details will be posted as they become available.
 
November 5, 2008
The ASM has drafted recommendations for the new Administration’s transition team on key issues regarding science, research and public health.